Evidence-based guidance for the management of postherpetic neuralgia in primary care.

Postgraduate medicine

Volumn 125, Issue 4, 2013, Pages 191-202

  Harden, R Norman ^a   Kaye, Alan David ^b   Kintanar, Thomas ^b   Argoff, Charles E ^b  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (((ALPHA ISOBUTANOYLOXYETHOXY)CARBONYL)AMINOMETHYL) 1 CYCLOHEXANEACETIC ACID; 1-(((ALPHA-ISOBUTANOYLOXYETHOXY)CARBONYL)AMINOMETHYL)-1-CYCLOHEXANEACETIC ACID; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CAPSAICIN; CARBAMIC ACID DERIVATIVE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; GABAPENTIN; PREGABALIN;

EVIDENCE BASED MEDICINE; HUMAN; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; REVIEW;

AMINES; ANALGESICS; CAPSAICIN; CARBAMATES; CYCLOHEXANECARBOXYLIC ACIDS; EVIDENCE-BASED MEDICINE; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA, POSTHERPETIC; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE;

EID: 84885943491     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.07.2690     Document Type: Review

References (0)